Patient population for bioequivalence study [Regulatives / Guidelines]

posted by pash413 – India, 2017-10-06 17:33 (2391 d 00:37 ago) – Posting: # 17867
Views: 3,325

Dear David
Thanks for the reply.
We are talking about the generic drug with PK endpoint study submission.

Complete thread:

UA Flag
Activity
 Admin contact
22,991 posts in 4,827 threads, 1,648 registered users;
53 visitors (2 registered, 51 guests [including 3 identified bots]).
Forum time: 18:10 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5